What does TFBS Bioscience Inc. do?

TFBS Bioscience Inc. (6939.TWO) operates in the Medical - Diagnostics & Research industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

What is 6939.TWO's market cap?

TFBS Bioscience Inc. (6939.TWO) has a market capitalization of approximately $675.9 million, as of August 28, 2026, based on the most recent share price and shares outstanding.

Does 6939.TWO pay a dividend?

Yes — TFBS Bioscience Inc. (6939.TWO) has a dividend payment history. The most recent payment, frequency, and full history are on the Dividend tab.

Is 6939.TWO profitable?

TFBS Bioscience Inc. (6939.TWO) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

6939.TWO

TFBS Bioscience Inc.

TWO·Medical, Diagnostics & Research · Healthcare

NT$19.30NT$0.45−2.28%

Market capNT$675.87M·Aug 28 6:47 AM UTC

Price Chart

NT$19.30−NT$0.45 (−2.28%)today

−69.12%CAGR −30.07%

Select date range

FromTo

May 16, 2023May 16, 2023 → Aug 28, 2026· 3.3 yrsAug 28, 2026

Key Metrics

DividendDividend Tab

Dividend Yield (FWD)0.00%

Annual Dividend (FWD)NT$0.00

Dividend Growth (5Y)—

Dividend Safety—

Payout Ratio—

FCF Payout Ratio—

Most Recent DividendNT$0.050

Ex-Dividend DateAug 9

Payment DateSep 4

EarningsEarnings Tab

EPS (FWD)—

P/E Ratio (FWD)—

EPS Growth (1Y)—

EPS Growth (3Y)—

EPS Growth (5Y)—

Next Earnings Date—

Last Report Date—

Reported vs Estimate—

Earnings Surprise—

FinancialsFinancials Tab

RevenueNT$196.44M

Net Income−NT$65.98M

Net Margin−33.6%

Operating Cash FlowNT$2.02M

Capital ExpendituresNT$114.45M

Free Cash Flow−NT$112.43M

Return on Equity−5.8%

Return on Invested Capital−2.4%

Net CashNT$184.88M

Value Graph

PRO

See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.

Click below to see what's inside, then upgrade to unlock for 6939.TWO and 80,000+ other tickers.

EPS · Price vs. Fair Value Price Fair

Income Statement Flow

PRO

See exactly how 6939.TWO's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.

The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for 6939.TWO and 80,000+ other tickers.

About TFBS Bioscience Inc.

TFBS Bioscience Inc. functions as a contract research organization (CRO), specializing in offering biological analysis and testing services throughout Taiwan. The company plays a crucial role in supporting advanced medical innovations by fabricating viral vectors, which are essential for cell and gene therapy products. Furthermore, TFBS Bioscience conducts comprehensive biosafety and final product release evaluations for a diverse range of biopharmaceutical items, including cell and gene therapies, vaccines, and other biologics. Established in 2016, the firm's main operational base is located in New Taipei City, Taiwan.

CEO: Tatung Yuan
Sector: Healthcare
Industry: Medical - Diagnostics & Research
Exchange: TWO
Employees: 85
Website: www.tfbsbio.com

Peers

Peers Tab

4188.TWO

AmCad BioMed Corporation

Cap

NT$1.0B

3373.TWO

Radiant Innovation Inc.

Latest News

News Tab

No recent news available.

Frequently Asked Questions About 6939.TWO

What does TFBS Bioscience Inc. do?: TFBS Bioscience Inc. (6939.TWO) operates in the Medical - Diagnostics & Research industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.
What is 6939.TWO's market cap?: TFBS Bioscience Inc. (6939.TWO) has a market capitalization of approximately $675.9 million, as of August 28, 2026, based on the most recent share price and shares outstanding.
Does 6939.TWO pay a dividend?: Yes — TFBS Bioscience Inc. (6939.TWO) has a dividend payment history. The most recent payment, frequency, and full history are on the Dividend tab.
Is 6939.TWO profitable?: TFBS Bioscience Inc. (6939.TWO) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.